Among those, there were variants located in genes that involve in the immune system (e.g., CDHR3) and nervous system (e.g., TCEANC2), suggesting a possible role of one or a combination of these variants in increased MS risk together with the accumulation of common MS-associated variants in this family. This evidence concerns the gene TCEANC2 and myeloid sarcoma.